M. Kulyk & Associates
MRK icon

M. Kulyk & Associates’s Merck MRK Stock Holding History

M. Kulyk & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.5M Sell
92,793
-2,070
-2% -$286K 2.25% 11
2026
Q2 		$12.2M Sell
94,863
-3,331
-3% -$390K 1.99% 14
2026
Q1 		$11.8M Buy
98,194
+577
+0.6% +$66.6K 2.2% 12
2025
Q4 		$10.3M Buy
97,617
+1,078
+1% +$101K 1.96% 16
2025
Q3 		$8.1M Buy
96,539
+6,295
+7% +$518K 1.65% 18
2025
Q2 		$7.14M Buy
90,244
+15,583
+21% +$1.24M 1.55% 21
2025
Q1 		$6.7M Buy
74,661
+6,216
+9% +$580K 1.53% 22
2024
Q4 		$6.81M Buy
68,445
+3,573
+6% +$368K 1.47% 23
2024
Q3 		$7.37M Buy
64,872
+2,096
+3% +$249K 1.48% 24
2024
Q2 		$7.77M Buy
62,776
+394
+0.6% +$50.8K 1.81% 16
2024
Q1 		$8.23M Buy
62,382
+1,534
+3% +$189K 1.91% 15
2023
Q4 		$6.63M Buy
60,848
+3,720
+7% +$386K 1.55% 24
2023
Q3 		$5.88M Buy
57,128
+9,080
+19% +$979K 1.63% 20
2023
Q2 		$5.54M Sell
48,048
-1,646
-3% -$187K 1.55% 24
2023
Q1 		$5.29M Buy
49,694
+2,211
+5% +$239K 1.6% 25
2022
Q4 		$5.27M Buy
47,483
+925
+2% +$94.6K 1.76% 22
2022
Q3 		$4.01M Buy
+46,558
New +$4.16M 1.39% 26
2022
Q2 		– Sell
-3,100
Closed -$254K – 102
2022
Q1 		$254K Sell
3,100
-1,390
-31% -$110K 0.07% 92
2021
Q4 		$344K Buy
4,490
+1,400
+45% +$112K 0.09% 70
2021
Q3 		$232K Buy
3,090
+359
+13% +$27.3K 0.07% 66
2021
Q2 		$212K Sell
2,731
-131
-5% -$9.7K 0.08% 62
2021
Q1 		$211K Sell
2,862
-103
-3% -$7.6K 0.08% 72
2020
Q4 		$231K Buy
+2,965
New +$227K 0.13% 49

Other funds holding MRK

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

M. Kulyk & Associates's MRK Position: Q3 2026 in Review

M. Kulyk & Associates reduced its Merck (MRK) stake by 2.2% in Q3 2026, selling an estimated $286K and leaving 92,793 shares worth $13.5M. The position accounts for 2.25% of the portfolio, ranked #11.

M. Kulyk & Associates first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • M. Kulyk & Associates held 92,793 shares of Merck worth $13.5M as of Q3 2026.
  • M. Kulyk & Associates sold 2,070 Merck shares in Q3 2026, an estimated $286K.
  • Merck made up 2.25% of M. Kulyk & Associates's portfolio in Q3 2026, its #11 holding.
  • M. Kulyk & Associates first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on M. Kulyk & Associates's 13F filing for Q3 2026, filed 10 Nov 2026.